Jingjing Liu

Affiliations: 
2013-2014 Ophthalmic Research Cleveland Clinic Foundation, Cleveland, OH, United States 
Area:
Experimental Eye Research
Google:
"Jingjing Liu"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liu J, Wei Z, Meng L, et al. (2024) CircJPH1 regulates the NF-κB/HERC5 axis to promote the malignant progression of esophageal squamous cell carcinoma through binding to XRCC6. Cellular Signalling. 124: 111403
Yang FF, Liu JJ, Xu XL, et al. (2024) Discovery of Novel Imidazo[1,2-]pyridine-Based HDAC6 Inhibitors as an Anticarcinogen with a Cardioprotective Effect. Journal of Medicinal Chemistry
Liu J, Jing W, Wang T, et al. (2022) Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer. Pharmacological Research. 106554
Pribnow A, Jonchere B, Liu J, et al. (2022) Combination of ribociclib and gemcitabine for the treatment of medulloblastoma. Molecular Cancer Therapeutics
Liu J, Liu X, Wu M, et al. (2020) Engineering Living Mitochondria with AIE Photosensitizer for Synergistic Cancer Cell Ablation. Nano Letters
Li H, Liu Y, Liu X, et al. (2020) A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer. Anti-Cancer Drugs
Liu J, Luo X, Guo R, et al. (2020) Cell metabolomics reveal berberine inhibited pancreatic cancer cell viability and metastasis by regulating citrate metabolism. Journal of Proteome Research
Yang J, Lian Y, Yang R, et al. (2020) Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes. Molecular Therapy. Nucleic Acids. 19: 1164-1175
Pan T, Zhou D, Shi Z, et al. (2019) Centromere Protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2. Cancer Letters
Hu M, Chen C, Liu J, et al. (2019) The melanogenic effects and underlying mechanism of paeoniflorin in human melanocytes and vitiligo mice. Fitoterapia. 104416
See more...